A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (clinicaltrials.gov) - Sep 22, 2026 - P1 | N=58 | Completed | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Cardiomyopathy • Cardiovascular
|